脑部放疗，上午比下午敏感许多！
' `3 Q; ?/ D* v5 P' ~1 a5 r9 |( b9 x6 Z4 Q, P- ~; \/ T
6 W7 }+ q. o# ~
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
5 v) ~7 }1 F; |& _: h" n. y. PGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
3 e- G% p# g* C9 bRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
" v3 s0 P7 k" k$ ]6 ZSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
) c3 j; ~$ i) q1 r: V
! N6 T& d2 c& yAbstract! n2 a2 O: G) v3 g5 i( ^. S0 u
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time., D$ o" k4 t4 H- E. y
( d6 E9 l& l! |5 X: L% @& W' |
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
2 h$ g0 k5 d- R! L. k7 A% i h+ {7 @( l0 k1 e4 E0 y9 H7 K
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).9 H# w" z9 g/ U0 G+ \# V' Y$ {
& r# W: Y h: v8 G, xCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.; e# o" c: u# l- g% v. n8 \
o. c# }' A% f. X+ A" ~ i
|
5 Y2 {6 g5 c, S. d6 L
显身卡
